Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.7B | 5.4B | 5.9B | 4.9B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | -1.8B | 3.3B | -5.1B | 7.6B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.3B | 1.7B | 947.3M | 2.1B |
| Tax provision | 663.3M | 440.3M | 142.6M | 563.3M |
| Net income | 1.6B | 1.3B | 804.7M | 1.5B |
| Basic EPS | — | 0.0 | — | — |
| Diluted EPS | — | 0.0 | — | — |
| Basic average shares | — | 69.7B | — | — |
| Diluted average shares | — | 69.7B | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | -14.9M | — | — |
| Preferred stock dividends | 134.5M | 147.1M | 87.4M | 175.9M |